T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma. [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating HSP-CAR30 CAR T-cells targeting CD30 for relapsed/refractory Hodgkin lymphoma and T-cell lymphoma is o…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: A Study for Patients With Non-Hodgkin's Lymphomas [Phase 2]
Phase 2 trial update for a study in non-Hodgkin's lymphomas has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients [Phase 1]
A Phase 1 pilot trial evaluating sorafenib biomarkers in patients with refractory or relapsed T-cell lymphoma has completed enrollment with …
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma [Phase 1]
Phase 1 trial assessing safety and efficacy of a dual PI3K Delta/Gamma inhibitor in T-cell lymphoma types; study completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas [Phase 3]
Phase 3 trial comparing Brentuximab Vedotin + CHP versus standard CHOP in CD30-positive mature T-cell lymphomas completed; results posted in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas [Phase 2]
Phase 2 trial update of pembrolizumab for T-cell lymphoma and NK-cell lymphoma is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies [Phase 2]
Phase II study evaluating Roferon and Accutane in patients with T-cell malignancies completed.
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study of alisertib (MLN8237) in adults with aggressive non-Hodgkin lymphoma, including diffuse large B-cell lymphoma and mantle ce…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms [Phase 1]
Phase 1 study of brentuximab vedotin given sequentially and in combination with multi-agent chemotherapy for CD30-positive mature T-cell and…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Tandem Auto-Allo Transplant for Lymphoma [Phase 2]
Phase 2 clinical trial update on tandem auto-allo transplantation for various lymphomas, with completed status and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma [EARLY_Phase 1]
A Phase 1 pilot study of Oncaspar (pegaspargase) plus dexamethasone in relapsed or refractory T-cell lymphoma was terminated early.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: AMG 319 Lymphoid Malignancy FIH [Phase 1]
First-in-human Phase 1 clinical trial update for AMG 319 in lymphoid malignancies, including chronic lymphocytic leukemia and various lympho…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: A Phase II Study of Doxycycline in Relapsed NHL [Phase 2]
Phase II trial of doxycycline in relapsed non-Hodgkin lymphoma was terminated and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) [Phase 2]
Phase 2 trial of A-dmDT390-bisFv(UCHT1) immunotoxin for cutaneous T-cell lymphoma (CTCL) has completed, with results from the study summariz…
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial of Brentuximab Vedotin in relapsed or refractory non-Hodgkin lymphoma has completed and results have been posted. The study …
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies [Phase 1]
Phase 1 study of idelalisib (IPI-145) in combination with Rituximab or Bendamustine/Rituximab in hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies [Phase 1]
Phase 1 study of a dual PI3K Delta/Gamma inhibitor in B-cell and T-cell lymphomas has completed, assessing safety and preliminary efficacy.
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas [Phase 2]
Phase 2 clinical trial update evaluating Campath-1H with EPOCH for T-cell and NK/T-cell lymphomas has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Trial of Endostar Combined With CHOPT for T Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating Endostar in combination with CHOPT chemotherapy for T-cell lymphoma. The trial status is currently unkno…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma [Phase 2]
This Phase 2 trial update describes BuEAM conditioning with busulfan, etoposide, cytarabine, and melphalan before autologous stem cell trans…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma [Phase 2]
Phase 2 study evaluating fostamatinib disodium for T-cell lymphoma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies [Phase 1]
A Phase 1 study of oral forodesine hydrochloride (BCX-1777) in patients with recurrent or refractory T/NK-cell malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Aminocamptothecin in Treating Patients With T-cell Lymphoma [Phase 2]
Update on a Phase 2 trial evaluating aminocamptothecin in patients with T-cell lymphoma, noting completed status.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating dexamethasone followed by denileukin diftitox in persistent or recurrent T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating bendamustine in patients with refractory or relapsed T-cell lymphoma has completed.